Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billionPUBT·15 hours ago02196+0.79%00656+1.35%
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian marketsPUBT·Jul 16 at 06:33 AMVRAX+1.38%02196+0.79%
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement | VRAX Stock NewsStockTitan·Jul 15 at 10:30 PMVRAX+1.38%600196+4.00%
Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemiaPUBT·Jul 15 at 05:14 AM02196+0.79%600196+4.00%
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Hold from HSBCTip Ranks·Jul 13 at 07:27 PM600196+4.00%02196+0.79%
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watchrttnews·Jul 9 at 09:55 PMFBRX-0.16%CNTB-1.44%
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics | VRAX Stock NewsStockTitan·Jul 8 at 10:30 PMVRAX+1.38%02196+0.79%
JUNSHI BIO Opens 11.11% Higher After Signing Licensing Agreement with Fosun WanbangAASTOCKS News·Jul 1 at 08:50 PM01877-0.22%688180-0.28%
